VarmX
Netherlands - LeidenBiotechnology
Focus: VarmX is a Netherlands-based biotechnology company focused on hemostasis therapies and biologics development. The company operates at a pre-revenue stage with a highly focused pipeline centered on a single lead asset.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About VarmX
AI assessmentNot HiringNo open roles listed right now. Follow VarmX to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
VMX-C001
Coagulation DisorderClinical Trials (1)
NCT06372483Single Dose Trial of VMX-C001 in Healthy Subjects with and Without FXa Direct Oral Anticoagulant
Phase 1Help build intelligence for VarmX
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.